265 related articles for article (PubMed ID: 23785279)
1. Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.
Kosinska AD; Zhang E; Johrden L; Liu J; Seiz PL; Zhang X; Ma Z; Kemper T; Fiedler M; Glebe D; Wildner O; Dittmer U; Lu M; Roggendorf M
PLoS Pathog; 2013; 9(6):e1003391. PubMed ID: 23785279
[TBL] [Abstract][Full Text] [Related]
2. DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.
Kosinska AD; Johrden L; Zhang E; Fiedler M; Mayer A; Wildner O; Lu M; Roggendorf M
J Virol; 2012 Sep; 86(17):9297-310. PubMed ID: 22718818
[TBL] [Abstract][Full Text] [Related]
3. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.
Lu M; Hilken G; Kruppenbacher J; Kemper T; Schirmbeck R; Reimann J; Roggendorf M
J Virol; 1999 Jan; 73(1):281-9. PubMed ID: 9847331
[TBL] [Abstract][Full Text] [Related]
4. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
[TBL] [Abstract][Full Text] [Related]
5. Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.
Liu J; Zhang E; Ma Z; Wu W; Kosinska A; Zhang X; Möller I; Seiz P; Glebe D; Wang B; Yang D; Lu M; Roggendorf M
PLoS Pathog; 2014 Jan; 10(1):e1003856. PubMed ID: 24391505
[TBL] [Abstract][Full Text] [Related]
6. Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.
Lu M; Isogawa M; Xu Y; Hilken G
J Virol; 2005 May; 79(10):6368-76. PubMed ID: 15858020
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection.
Siegel F; Lu M; Roggendorf M
J Virol; 2001 Jun; 75(11):5036-42. PubMed ID: 11333883
[TBL] [Abstract][Full Text] [Related]
8. Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens.
Lu M; Klaes R; Menne S; Gerlich W; Stahl B; Dienes HP; Drebber U; Roggendorf M
J Hepatol; 2003 Sep; 39(3):405-13. PubMed ID: 12927927
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model.
Lu M; Roggendorf M
Intervirology; 2001; 44(2-3):124-31. PubMed ID: 11509873
[TBL] [Abstract][Full Text] [Related]
10. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope.
Menne S; Maschke J; Tolle TK; Lu M; Roggendorf M
J Virol; 1997 Jan; 71(1):65-74. PubMed ID: 8985324
[TBL] [Abstract][Full Text] [Related]
11. Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide.
Frank I; Budde C; Fiedler M; Dahmen U; Viazov S; Lu M; Dittmer U; Roggendorf M
J Virol; 2007 Jul; 81(13):7156-63. PubMed ID: 17459928
[TBL] [Abstract][Full Text] [Related]
12. Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.
Menne S; Roneker CA; Korba BE; Gerin JL; Tennant BC; Cote PJ
J Virol; 2002 Jun; 76(11):5305-14. PubMed ID: 11991959
[TBL] [Abstract][Full Text] [Related]
13. Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.
Liu KH; Ascenzi MA; Bellezza CA; Bezuidenhout AJ; Cote PJ; Gonzalez-Aseguinolaza G; Hannaman D; Luxembourg A; Evans CF; Tennant BC; Menne S
J Virol; 2011 May; 85(10):4853-62. PubMed ID: 21389124
[TBL] [Abstract][Full Text] [Related]
14. Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.
Cote PJ; Butler SD; George AL; Fairman J; Gerin JL; Tennant BC; Menne S
J Med Virol; 2009 Oct; 81(10):1760-72. PubMed ID: 19697409
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of woodchuck hepatitis virus infection of peripheral blood mononuclear cells by flow cytometry and polymerase chain reaction.
Chemin I; Baginski I; Vermot-Desroches C; Hantz O; Jacquet C; Rigal D; Trepo C
J Gen Virol; 1992 Jan; 73 ( Pt 1)():123-9. PubMed ID: 1730932
[TBL] [Abstract][Full Text] [Related]
16. Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.
Su J; Brunner L; Ates Oz E; Sacherl J; Frank G; Kerth HA; Thiele F; Wiegand M; Mogler C; Aguilar JC; Knolle PA; Collin N; Kosinska AD; Protzer U
J Hepatol; 2023 Apr; 78(4):717-730. PubMed ID: 36634821
[TBL] [Abstract][Full Text] [Related]
17. Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus.
Fiedler M; Kosinska A; Schumann A; Brovko O; Walker A; Lu M; Johrden L; Mayer A; Wildner O; Roggendorf M
J Virol; 2013 Jul; 87(13):7708-16. PubMed ID: 23637419
[TBL] [Abstract][Full Text] [Related]
18. Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.
Korba BE; Cote PJ; Menne S; Toshkov I; Baldwin BH; Wells FV; Tennant BC; Gerin JL
Antivir Ther; 2004 Dec; 9(6):937-52. PubMed ID: 15651753
[TBL] [Abstract][Full Text] [Related]
19. The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.
Roggendorf M; Kosinska AD; Liu J; Lu M
Cold Spring Harb Perspect Med; 2015 Oct; 5(12):. PubMed ID: 26511761
[TBL] [Abstract][Full Text] [Related]
20. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
